Comparison of the effects of tocopherol and tocotrienol on osteoporosis in animal models

International Journal of Pharmacology

Volumn 6, Issue 5, 2010, Pages 561-568

  Nazrun, A S ^a   Norazlina, M ^a   Norliza, M ^a   Ima Nirwana, S ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Anti oxidant; Histomorphometry; Osteocalcin; Remodeling; Vitamin E

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; BIOCHEMICAL MARKER; CALCIUM; DEOXYPYRIDINOLINE; GAMMA TOCOTRIENOL; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOCALCIN; TOCOPHEROL;

ARTICLE; BONE DENSITY; BONE METABOLISM; BONE STRENGTH; BONE STRUCTURE; CALCIUM BONE LEVEL; COMPARATIVE STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; OXIDATIVE STRESS; PATHOGENESIS; POSTMENOPAUSE OSTEOPOROSIS; PROTECTION; PROTEIN FUNCTION; VITAMIN SUPPLEMENTATION;

EID: 77955707225     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.561.568     Document Type: Article

References (55)

1. Abe, T., J.W.M. Chow, J.M. Lean and T.J. Chambers, 1993. Estrogen does not restore bone lost after ovariectomy in the rat. J. Bone Mineral Res., 8: 831-838.
2. Ahmad, N.S., B.A.K. Khalid, D.A. Luke and S. Ima-Nirwana, 2005. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin. Exp. Pharm. Physiol., 32: 761-770.
3. Akesson, K., S. Ljunghall, B. Jonsson, I. Sernbo, O. Johnell, P. Gardsell and K.J. Obrant, 1995. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women. J. Bone Miner. Res., 10: 1823-1829.
4. Black, D., A. Duncan and S.P. Robins, 1988. Quantitative analysis of the pyridinoline crosslinks of collagen in urine using ion paired re versed-phase-high performance liquid chromatography. Anal. Biochem., 169: 197-203.
5. Boyce, B.F., T.B. Aufdemorte, I.R. Garrett, A.J. Yates and G.R. Mundy, 1989. Effects of mterleukin-1 on bone turnover in normal mice. Endocrinology, 125: 1142-1150.
6. Brigelius-Flohe, R., 2003. Vitamin E and drug metabolism. Biochem. Biphys. Res. Comm., 305: 737-740.
7. Carballo, M., M. Conde, R.E. Bekay, J. Martin-Nieto and M.J. Camacho et al., 1999. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J. Biol. Chem., 274: 17580-17586.
8. Cohen, S., E. Hurd and J.J. Cush, 1999. Treatment of interleukin -1 receptor antagonist in combination with methotrexate (MTX) in rheumatoid arthritis patients. Arthritis Rheum., 42: S273-S273.
9. Compston, J.E. and P.I. Crouchier, 1991. Histomorphometric analysis of trabecular bone remodelling in osteoporosis. Bone Mineral., 14: 91-102.
10. Conte, C, A. Flondi, C. Aisa, M. Piroddi, A. Flondi and F. Galli, 2004. Gamma-tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Ann. N. Y. Acad. Sci., 1031: 391-394.
11. De Vernejoul, M.C., A. Pointillart, C. Golenzer, C. Morieux and C. Bielakoff et al, 1984. Effects of iron overload on bone remodeling in pigs. Am. Pathol., 116: 377-384.
12. Delmas, P.D., 1992. Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone, 13: S17-S21.
13. Eastell, R., S.P. Robins, T. Colwell, A.M.A. Assiri, B.L. Riggs and R.G.G. Russell, 1993. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteopor. Int., 3: 255-260.
14. Ebina, Y., S. Okada, S. Hamazaki, Y. Toda and O. Midorikawa, 1991. Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes. Calcified Tissue Int., 48: 28-36.
15. Eyre, D.R., I.R. Dickson and K.P. Van-Ness, 1988. Collagen cross linking in human bone and articular cartilage. Age-related changes in the content of mature hydoxypyridiniumresidues. Biochem. J., 252: 495-500.
16. Fang, M.A., P.J. Frost, A. lika-Klem and T.J. Hahn, 1991. Effects of nicotine on cellular function in UMR106-01 osteoblast-like cells. Bone, 12: 283-286.
17. Gowen, M., D.D. Wood, E.J. Ihrie, M.K. McGuire and R.G. Russell, 1983. An interleukin 1 like factor stimulates bone resorption in vitro. Nature, 306: 378-380.
18. Guba, S.C., C.I. Sartor, L.R. Gottschalk, Y.H. Jmg, T. Mulligan and S.G. Emerson, 1992. Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: Demonstration by serum-free bioassay, enzymelinked immunosorbent assay, and reverse transcriptase polymerase chain reaction. Blood, 80: 1190-1198.
19. Hasselwander, O., K. Kramer, P.P. Hoppe, U. Oberfrank and K. Baldenius et al, 2002. Effects of feeding various tocotrienol sources on plasma lipids and aortic atherosclerotic lesions in cholesterol-fed rabbits. Food Res. Int., 35: 245-251.
20. Helen, A., K. Krishnakumar, P.L. Vijayammal and K.T. Augusti, 2000. Antioxidant effect of onion oil (Allium cepa. Linn) on the damages induced by nicotine in rats as compared to alpha-toe opherol. Toxicol. Lett., 116: 61-68.
21. Henemyre, C.L., D.K. Scales, S.D. Hokett, M.F. Cuenin and M.E. Peacock et al, 2003. Nicotines stimulates osteoclast resorption in a porcine marrow cell model. J. Periondotol., 74: 1440-1446.
22. Hermizi, H., O. Faizah, S. Ima-Nirwana, A.S. Nazrun, D.A. Luke and M. Norazlina, 2009. Beneficial effects of tocotrienol on bone histomorphometric parameters in Sprague-Dawley male rats after nicotine cessation. Calcified Tissue Int., 84: 65-74.
23. Hosomi, A., M. Arita, Y. Sato, C. Kiyose and T. Ueda et al, 1997. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin Eanalogs. FEBS Lett, 409: 105-108.
24. Ima-Nirwana, S., M. Norazlina and B.A.K. Khahd, 1998. Pattern of bone mineral density in growing male and female rats after gonadectomy. J. Asean. Fed. Endoc. Soc, 16: 21-26.
25. Ima-Nirwana, S., A. Kiftiah, T. Sariza, M.T. Gapor and B.A.K. Khalid, 1999. Palm vitaminE improves bone metabolism and survival rate in thyrotoxic rats. Gen. Pharm.,32: 621-626.
26. Ima-Nirwana, S., A. Kiftiah, A.G. Zainal, M.A. Norazlina, M.T. Gapor and B.A.K. Khalid, 2000. Palm vitamin E prevents osteoporosis in orchidectomised growing male rats. Nat. Prod. Sci., 6: 155-160.
27. Ima-Nirwana, S. and S. Suhaniza, 2004. Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomised rats replaced wiih Dexamethasone. J. Med. Food, 7: 45-51.
28. Jee, W.S.S., 1995. Animal models in the prevention and treatment of osteopenia: Forward. Bone, 17: 113S-114S.
29. Kalu, D.N., 1991. The ovariectomized rat model of postmenopausal bone loss. Bone Miner., 15: 175-191.
30. Key, L.L., W.L. Ries, R.G. Taylor, B.D. Hays and B.L. Pitzer, 1990. Oxygen derived free radicals in osteocasts: the location and specificity of nitroblue tetrazolium reaction. Bone, 11: 115-119.
31. Kurihara, N, T. Suda, Y. Miura, H. Nakauchi and H. Kodama et al, 1989. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood, 74: 1295-1302.
32. Maggio, D., M. Barabani, M. Pierandrei, M.C. Polidori and M. Catani et al, 2003. Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. J. Clin. Endo. Metab., 88: 1523-1527.
33. Maniam, S., N. Mohamed, A.N. Shuid and I.N. Soelaiman, 2008. Palm tocotrienol exerted better antioxidant activities in bone than alpha-tocopherol. Basic Clin. Pharmacol. Toxicol., 103: 55-60.
34. McSheehy P.M. and T. J. Chambers, 1986. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology, 119: 1654-1659.
35. Mosekilde, L., 1995. Assessing bone quality-animal models in preclinical osteoporosis research. Bone, 17: 343S-352S.
36. Nazrun, A.S., M. Zulfadli, M. Norliza, M. Norazlina and S. ImaNirwana, 2010. VitaminE exhibit bone anabolic properties. J. BoneMin. Metab., 28: 149-156.
37. Nelson, H.D., M. Helfand, S.H. Woolf and J.D. Allan, 2002. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services task force. Ann. Intern. Med., 137: 529-541.
38. Nesaretnam, K., R. Ambra, K.R. Selvaduray, A. Radhakrishnan, R. Canali and F. Virgili, 2004. Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann. N. Y. Acad. Sci., 1031: 143-157.
39. Norazlina, M., S. Ima-Nirwana, M.T. Gapor and B.A.K. Khalid, 2000. Palm vitamin E is comparable to α-tocopherol in maintaining bone mineral density in ovariectomised female rats. Exp. Clin. Endocrinol. Diab., 108: 305-310.
40. Norazlina, M., S. Ima-Nirwana, M.T. Gapor and B.A.K. Khalid, 2002. Tocotrienols are needed for bone calcification in growing female rats. Asia Pacific J. Clin.Nutr., 11: 194-199.
41. Norazlina, M., Y.M.K. Nik-Farideh, A. Arizi, A. Faisal and S. Ima-Nirwana, 2004. Effects of nicotine on bone resorbing cytokines in male rats. Int. Med. J., 3: 1-9.
42. Norazlina, M., H.I. Lukman, A.S. Nazrun and S. Ima-Nirwana, 2007. Effects of vitamin E supplementation on bone metabolism in nicotine-treated rats. Singapore Med. J., 48: 195-199.
43. Norazlina, M., J. Maizatul-Neza, A. Azarina, A.S. Nazrun, M. Norliza and S. Ima-Nirwana, 2010. Effects of vitamin E on Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) and Osteoprotegerin (OPG) in rats treated with nicotine. Med. J. Malaysia, 65: 14-17.
44. Omi, N. and I. Ezawa, 1995. The effect of ovariectomy on bone metabolism in rats. Bone, 17: 163S-168S.
45. Papanicolaou, D.A. and A.N. Vgontzas, 2000. Interleukin- 6: The endocrine cytokine. J. Clin. Endocrinol. Metab., 85: 1331-1333.
46. Ramp, W.K., L.G. Lenz and R.J. Galvin, 1991. Nicotine inhibits collagen synthesis and alkaline phosphatase activity but stimulates DNA synthesis in osteoblast-like cells. Proc. Soc. Exp. Biol. Med., 197: 36-43.
47. Sambrook, P. and C. Cooper, 2006. Osteoporosis. Lancet, 367: 2010-2018.
48. Schaafsma, M.R., W.E. Fibbe, J. Van Damme, N. Duinkerken and P. Ralph et al, 1989. Interleukin-6 is not involved in the interleukin-1-induced production of colony-stimulating factors by human bone marrow stromal cells and fibroblasts. Blood, 74: 2619-2623.
49. Serbinova, E., V. Kagan, D. Hanan, DL. Packer, 1991. Free radical recycling and intramembrane mobility in the antioxidant properties of a tocopherol and a-tocotrienol. Free Radical Biol. Med., 10: 263-275.
50. Sontakke, A.N. and R.S. Tare, 2002. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin. Chim. Acta, 318: 145-148.
51. Suda, T., N. Takahashi and T.J. Martin, 1992. Modulation of osteoclast differentiation. Endo Rev., 13: 66-80.
52. Takeuchi, K., S. Okada, S. Yukihiroan, DH. Inoue, 1997. The inhibitory effects of aluminium and iron on bone formation, in vivo and in vitro study. Pathophysiology, 4: 97-104.
53. Traber, M.G. and H. Sies, 1996. Vitamin E in humans: Demand and delivery. Ann. Rev. Nutr., 16: 321-347.
54. Visseren, F.L., M.S. Verkerk, T. van der Bruggen, J.J. Marx, B.S. vanAsbeck and R.J. Dipersloot, 2002. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur. J. Clin Invest., 32: 84-90.
55. Wetscher, G.J., M. Bagchi, D. Bagchi, G. Perdikis and P.R. Hinder et al, 1995. Free radical production in nicotine treated pancreatic tissue. Free Radical Biol. Med., 18: 877-882.